Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene

Psychopharmacology

Volumn 149, Issue 3, 2000, Pages 246-250

  Mihara, Kazuo ^a   Kondo, Tsuyoshi ^a   Suzuki, Akihito ^a   Yasui, Norio ^a   Nagashima, Udai ^a   Ono, Shingo ^a   Otani, Koichi ^b   Kaneko, Sunao ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

Dopamine D2 receptor; Nemonapride; Prolactin response; Schizophrenia; Taq1A polymorphism

Indexed keywords

BIPERIDEN; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; EMILACE; EMONAPRIDE; FLUNITRAZEPAM; PROLACTIN;

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; CORPUS STRIATUM; DNA POLYMORPHISM; DOSE CALCULATION; DRUG EFFECT; ENZYME IMMUNOASSAY; FEMALE; GENOTYPE; HUMAN; INSOMNIA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA;

ADOLESCENT; ADULT; ALLELES; BENZAMIDES; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROLACTIN; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; SEX FACTORS;

EID: 0034066621     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002139900364     Document Type: Article

References (25)

1. 2 receptor locus. Biol Psychiatry 34:204-209
2. 2 dopamine receptor A1 allele. Behav Genet 25:45-58
3. 2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. Pharmacogenetics 5:121-141
4. Davis KL, Kahn RS, Ko G, Davidson M (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148:1474-1486
5. Dickson RA, Glazer WM (1999) Neuroleptic-induced hyperprolactinemia. Schizophr Res 35:S75-S86
6. Grandy DK, Zhang Y, Civelli O (1993) PCR detection of the TaqA RFLP at the DRD2 locus. Hum Mol Genet 2:2197
7. Härnryd C, Bjerkenstedt L, Gullberg B, Oxenstierna G, Sedvall G, Wiesel FA (1984) Time course for effects of sulpiride and chlorpromazine on monoamine metabolite and prolactin levels in cerebrospinal fluid from schizophrenic patients. Acta Psychiatr Scand 69:75-92
8. Jönsson E, Brené S, Geijer T, Terenius L, Tylec A, Persson ML, Sedvall G (1996) A search for association between schizophrenia and dopamine-related alleles. Eur Arch Psychiatry Clin Neurosci 246:297-304
9. Linkowski P, Hubain P, von Frenckell R, Mendlewicz J (1984) Haloperidol plasma levels and clinical response in paranoid schizophrenics. Eur Arch Psychiatry Clin Neurosci 234:231-236
10. Meltzer HY, Bush DA, Fang VS (1983) Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response. Psychiatry Res 9:271-283
11. Nagasaki T, Ohkubo T, Sugawara K, Yasui N, Ohtani K, Kaneko S (1998) High-performance liquid chromatographic determination of nemonapride and desmethylnemonapride in human plasma using an electrochemical detection. J Chromatogr B 714:293-298
12. 2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 48:648-654
13. 2 dopamine receptor A1 allele. Am J Hum Genet 54:658-668
14. 2 dopamine receptor polymorphism and brain regional glucose metabolism. Am J Med Genet 74:162-166
15. 2 receptor occupancy in antipsychotic drug-treated patients. J Clin Psychopharmacol 18:305-310
16. Otani K, Kondo T, Ishida M, Sasa H, Higuchi H, Kaneko S, Fukushima Y (1993) Prolactin response to zotepine in schizophrenic patients. Hum Psychopharmacol 8:35-39
17. Otani K, Kondo T, Yasui N, Suzuki A, Furukori H, Kaneko S, Ohkubo T, Nagasaki T, Sugawara K, Hayashi K (1997) Prolactin response to nemonapride, a new antipsychotic drug, in schizophrenic patients. Hum Psychopharmacol 12:591-594
18. 2 receptor availability in healthy volunteers. Mol Psychiatry 3:256-260
19. Rubin RT (1987) Prolactin and schizophrenia. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 803-808
20. Satoh K, Someya T, Shibasaki M (1996) Effects of nemonapride on positive and negative symptoms of schizophrenia. Int Clin Psychopharmacol 11:279-281
21. Schotte A, Bonaventure P, Jannsen PFM, Leysen JE (1995) In vitro receptor binding and in vivo receptor occupancy in rat and guinea pig brain: risperidone compared with antipsychotic hitherto used. Jpn J Pharmacol 69:399-412
22. Seeman MV, Lang M (1990) The role of estrogens in schizophrenia gender differences. Schizophr Bull 16:185-194
23. 3H]raclopride for dopamine D-2 receptor binding to rat striatum. Eur J Pharmacol 173: 177-182
24. 2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7:479-484
25. Yasui N, Kondo T, Otani K, Ishida M, Mihara K, Suzuki A, Kaneko S, Inoue Y (1998) Prolactin response to bromperidol treatment in schizophrenic patients. Pharmacol Toxicol 82: 153-156